CCCC Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane

03

Prezzo $2.95

Capitalizzazione di Mercato (MRQ) $363M

P/E (TTM) -3.2

EPS (TTM) $-0.91

Ricavi (TTM) $35M

ROE (TTM) -48.1%

Intervallo 52 sett. $2–$5

CCCC Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione

04

intervallo

barre

La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.

Informazioni su C4 Therapeutics, Inc. - Common Stock Panoramica della società da Wikipedia

05 · wikidata

Wikidata ↗

settoreHealthcare industriaBiotechnology dipendenti104 paeseUS

Performance decennale Andamento di ricavi, utile netto, margini e EPS

06

Ricavi$36M

2021-12-31 → 2025-12-31

EPS$-1.27

2021-12-31 → 2025-12-31

Flusso di cassa libero$-99M

2020-12-31 → 2025-12-31

Margine netto-289.4%

2022-12-31 → 2025-12-31

Valutazione e Rapporti 07–12

Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?

Metrica	CCCC	media 5 anni	Mediana dei peer	Verdetto
P/E (TTM)	-3.2media 5 anni ≈-5.2	≈-5.2	·	·
P/S (TTM)	10.3media 5 anni ≈14.5	≈14.5	16.4	Valore equo
P/B (MRQ)	1.5media 5 anni ≈1.7	≈1.7	2.6	Valore equo
Prezzo / FCF (TTM)	-4.2media 5 anni ≈-5.9	≈-5.9	·	·
Prezzo / Flusso di cassa (TTM)	-4.3media 5 anni ≈-5.9	≈-5.9	·	·
Price / Tangible Book (Prezzo / Valore contabile tangibile)	1.1media 5 anni ≈1.7	≈1.7	·	·

La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.

Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC

Metrica	CCCC	media 5 anni	Mediana dei peer	Verdetto
Margine Operativo (TTM)	-319.0%media 5 anni ≈-435.8%	≈-435.8%	-164.6%	Debole
EBITDA Margin (Margine EBITDA)	-320.5%media 5 anni ≈-435.8%	≈-435.8%	-164.6%	Debole
Pretax Margin (Margine ante imposte)	-291.7%media 5 anni ≈-406.5%	≈-406.5%	-135.6%	Debole
Margine di Profitto Netto (TTM)	-289.4%media 5 anni ≈-409.6%	≈-409.6%	-245.9%	Sotto la media
ROA (TTM)	-30.9%media 5 anni ≈-27.5%	≈-27.5%	-27.3%	In linea
ROE (TTM)	-48.1%media 5 anni ≈-43.1%	≈-43.1%	-21.3%	Sotto la media
ROIC	-45.0%media 5 anni ≈-52.5%	≈-52.5%	-45.8%	In linea

Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio

Metrica	Tendenza 5 anni	CCCC	media 5 anni	Mediana dei peer	Verdetto
Rapporto corrente (MRQ)		5.4media 5 anni ≈6.5	≈6.5	5.4	In linea
Quick Ratio		2.3media 5 anni ≈2.7	≈2.7	2.7	Bassa liquidità

Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y

Metrica	Tendenza 5 anni	CCCC	media 5 anni	Mediana dei peer	Verdetto
Revenue YoY (Ricavi YoY)		1.0%media 5 anni ≈1.8%	≈1.8%	·	·
Revenue CAGR 3Y (CAGR Ricavi 3Y)		5.0%	·	·	·

Metriche per Azione EPS, valore contabile per azione, flusso di cassa per azione, dividendo per azione

Metrica	CCCC	media 5 anni	Mediana dei peer	Verdetto
EPS (Diluted) (EPS (Diluito))	$-1.27media 5 anni ≈$-1.98	≈$-1.98	·	·
Revenue / Share (Ricavi / Azione)	$0.43media 5 anni ≈$0.50	≈$0.50	·	·
Cash Flow / Share (Flusso di cassa / Azione)	$-1.19media 5 anni ≈$-1.61	≈$-1.61	·	·
Cash / Share (Liquidità / Azione)	$0.77media 5 anni ≈$1.16	≈$1.16	·	·

Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti

Metrica	CCCC	media 5 anni	Mediana dei peer	Verdetto
Asset Turnover (Rotazione delle attività)	0.1media 5 anni ≈0.1	≈0.1	0.2	Debole
Receivables Turnover (Rotazione dei crediti)	13.1media 5 anni ≈7.4	≈7.4	7.9	Di prim'ordine
Revenue / Employee (Ricavi / Dipendente)	≈$345.6K	·	·	·

valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana

Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili

14

Sorpresa media 21.7%

Prossimo report Nov 04, 2026

Periodo	Rapporto	EPS Actual	EPS Stimato	Sorpresa
30 Giugno 2026	Ago 5, 2026	$-0.18	$-0.23	22.0%
31 Marzo 2026		$-0.20	$-0.38	47.3%
31 Dicembre 2025		$-0.18	$-0.31	41.9%
30 Settembre 2025		$-0.44	$-0.41	-6.2%
30 Giugno 2025		$-0.37	$-0.39	5.5%
31 Marzo 2025		$-0.37	$-0.46	19.4%

Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario

15

Conto Economico 14

Metrica	2025	2024	2023	2022	2021
Revenue	$36M	$36M	$21M	$31M	$46M
R&D Expense	$104M	$111M	$118M	$118M	$95M
SG&A Expense	$36M	$42M	$42M	$43M	$33M
Operating Expenses	$151M	$155M	$160M	$161M	$128M
Operating Income	$-115M	$-120M	$-139M	$-130M	$-82M
Other Non-op	$10M	$14M	$8M	$1M	$-2M
Pretax Income	$-105M	$-105M	$-131M	$-128M	$-84M
Income Tax	$121.0K	$131.0K	$1M	$0	$0
Net Income	$-105M	$-105M	$-132M	$-128M	$-84M
EPS (Basic)	$-1.27	$-1.52	$-2.67	$-2.62	$-1.82
EPS (Diluted)	$-1.27	$-1.52	$-2.67	$-2.62	$-1.82
Shares (Basic)	82,894,459	69,372,993	49,640,505	48,861,665	46,041,733
Shares (Diluted)	82,894,459	69,372,993	49,640,505	48,861,665	46,041,733
EBITDA	$-115M	$-120M	$-139M	$-130M	$-82M

Stato Patrimoniale 22

Metrica	2025	2024	2023	2022	2021
Cash & Equivalents	$75M	$55M	$127M	$30M	$76M
Short-term Investments	·	·	·	·	$233M
Receivables	$2M	$3M	$12M	$1M	$6M
Prepaid Expense	$7M	$10M	$6M	$10M	$11M
Current Assets	$258M	$258M	$271M	$288M	$326M
PP&E (Net)	$5M	$6M	$7M	$7M	$3M
PP&E (Gross)	$16M	$15M	$15M	$16M	$10M
Accum. Depreciation	$11M	$9M	$8M	$8M	$7M
Other Non-current Assets	$4M	$3M	$3M	$2M	$544.0K
Total Assets	$359M	$350M	$376M	$431M	$507M
Accounts Payable	$858.0K	$1M	$1M	$1M	$5M
Current Liabilities	$33M	$45M	$43M	$45M	$51M
Capital Leases	$54M	$60M	$66M	$71M	$31M
Total Liabilities	$102M	$134M	$130M	$142M	$117M
Long-term Debt	·	·	$0	$11M	$11M
Total Debt	·	·	$0	$11M	$11M
Common Stock	$9.0K	$7.0K	$6.0K	$5.0K	$5.0K
Retained Earnings	$-739M	$-634M	$-528M	$-396M	$-268M
AOCI	$50.0K	$53.0K	$-127.0K	$-4M	$-775.0K
Stockholders' Equity	$257M	$216M	$246M	$289M	$390M
Liabilities + Equity	$359M	$350M	$376M	$431M	$507M
Shares Outstanding	96,914,418	70,625,899	60,467,188	48,966,216	48,688,875

Flusso di cassa 13

Metrica	2025	2024	2023	2022	2021
D&A	$2M	$2M	$2M	$2M	$1M
Stock-based Comp	$19M	$30M	$27M	$30M	$22M
Restructuring	$0	$2M	$0	·	·
Operating Cash Flow	$-99M	$-65M	$-107M	$-106M	$-87M
CapEx	$607.0K	$180.0K	$2M	$5M	$1M
Investing Cash Flow	$-9M	$-51M	$158M	$58M	$-189M
Stock Issued	·	·	$58M	$0	·
Stock Repurchased	$193.0K	$194.0K	$110.0K	$0	·
Net Stock Activity	$-193.0K	$-194.0K	$58M	·	·
Financing Cash Flow	$126M	$45M	$45M	$1M	$171M
Net Change in Cash	$19M	$-71M	$97M	$-46M	$-105M
Taxes Paid	$131.0K	$76.0K	·	·	·
Free Cash Flow	$-99M	$-65M	$-109M	$-111M	$-88M

Redditività 7

Metrica	2025	2024	2023	2022	2021
Operating Margin	-320.5%	-336.1%	-669.8%	-416.6%	·
Net Margin	-292.1%	-296.0%	-638.3%	-412.2%	·
Pretax Margin	-291.7%	-295.6%	-632.2%	·	·
EBITDA Margin	-320.5%	-336.1%	-669.8%	-416.6%	·
ROA	-29.6%	-29.0%	-32.8%	-27.3%	-18.5%
ROE	-48.8%	-45.9%	-57.3%	-42.2%	-21.3%
ROIC	-45.0%	-55.5%	-57.0%	·	·

Liquidità e Solvibilità 4

Metrica	2025	2024	2023	2022	2021
Current Ratio	7.8	5.7	6.3	6.5	6.4
Quick Ratio	2.3	1.3	3.2	0.7	6.1
Debt / Equity	·	·	0.0	0.0	0.0
LT Debt / Equity	·	·	0.0	0.0	0.0

Efficienza 2

Metrica	Tendenza	2025	2024	2023	2022	2021
Asset Turnover		0.1	0.1	0.1	0.1	·
Receivables Turnover		13.1	4.8	3.1	8.7	·

Per Azione 5

Metrica	2025	2024	2023	2022	2021
Book Value / Share	$2.65	$3.06	$4.07	$5.91	$8.00
Revenue / Share	$0.43	$0.51	$0.42	$0.64	·
Cash Flow / Share	$-1.19	$-0.94	$-2.15	$-2.17	·
Cash / Share	$0.77	$0.79	$2.09	$0.61	$1.56
EPS (TTM)	$-1.27	$-1.52	$-2.67	$-2.62	$-1.82

Tassi di Crescita 2

Metrica	Tendenza	2025	2024	2023	2022	2021
Revenue YoY		1.0%	71.4%	-33.2%	-32.1%	·
Revenue CAGR 3Y		5.0%	-8.1%	·	·	·

Valutazione (TTM) 14

Metrica	2025	2024	2023	2022	2021
Revenue TTM	$36M	$36M	$21M	$31M	$46M
Net Income TTM	$-105M	$-105M	$-132M	$-128M	$-84M
Market Cap	$185M	$254M	$342M	$289M	$1.57B
Enterprise Value	·	·	$215M	$271M	$1.27B
P/E	-1.5	-2.4	-2.1	-2.3	-17.7
P/S	5.1	7.1	16.5	9.3	34.2
P/B	0.7	1.2	1.4	1.0	4.0
P / Tangible Book	0.7	1.2	1.4	1.0	4.0
P / Cash Flow	-1.9	-3.9	-3.2	-2.7	-18.0
P / FCF	-1.9	-3.9	-3.1	-2.6	-17.8
EV / EBITDA	·	·	-1.5	-2.1	-15.5
EV / FCF	·	·	-2.0	-2.4	-14.4
EV / Revenue	·	·	10.4	8.7	27.7
Earnings Yield	-66.5%	-42.2%	-47.3%	-44.4%	-5.7%

Conto Economico 14

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue	$7M	$6M	$11M	$11M	$6M	$7M	$5M	$15M	$12M	$3M	$3M	$11M	$3M	$4M	$3M	$7M
R&D Expense	$24M	$25M	$25M	$26M	$26M	$27M	$33M	$32M	$24M	$23M	$30M	$28M	$30M	$29M	$31M	$30M
SG&A Expense	$9M	$9M	$9M	$9M	$9M	$9M	$10M	$12M	$10M	$10M	$10M	$11M	$10M	$11M	$10M	$10M
Operating Expenses	$33M	$34M	$34M	$46M	$35M	$36M	$43M	$44M	$33M	$35M	$41M	$39M	$40M	$40M	$41M	$39M
Operating Income	$-26M	$-28M	$-23M	$-34M	$-29M	$-29M	$-38M	$-28M	$-21M	$-32M	$-37M	$-28M	$-38M	$-36M	$-38M	$-32M
Other Non-op	$3M	$3M	$3M	$2M	$2M	$3M	$3M	$4M	$4M	$4M	$3M	$2M	$2M	$1M	$1M	$530.0K
Pretax Income	·	·	$-20M	$-32M	$-26M	$-26M	$-34M	$-25M	$-18M	$-28M	$-34M	$-26M	$-36M	$-35M	$-37M	$-32M
Income Tax	$0	$0	$121.0K	$0	$0	$0	$131.0K	$0	$0	$0	$277.0K	$1M	$0	$0	$0	$0
Net Income	$-24M	$-25M	$-20M	$-32M	$-26M	$-26M	$-35M	$-25M	$-18M	$-28M	$-35M	$-27M	$-36M	$-35M	$-37M	$-32M
EPS (Basic)	$-0.18	$-0.20	$-0.09	$-0.44	$-0.37	$-0.37	$-0.50	$-0.35	$-0.26	$-0.41	$-0.68	$-0.55	$-0.73	$-0.71	$-0.76	$-0.65
EPS (Diluted)	$-0.18	$-0.20	$-0.09	$-0.44	$-0.37	$-0.37	$-0.50	$-0.35	$-0.26	$-0.41	$-0.68	$-0.55	$-0.73	$-0.71	$-0.76	$-0.65
Shares (Basic)	130,696,742	126,074,555	·	72,563,311	71,005,743	70,833,044	·	69,627,190	68,810,259	68,432,168	·	49,212,126	49,063,631	49,032,319	·	48,921,928
Shares (Diluted)	130,696,742	126,074,555	·	72,563,311	71,005,743	70,833,044	·	69,627,190	68,810,259	68,432,168	·	49,212,126	49,063,631	49,032,319	·	48,921,928
EBITDA	$-26M	$-27M	·	$-34M	$-29M	$-29M	·	$-28M	$-21M	$-32M	·	$-28M	$-38M	$-36M	·	$-32M

Stato Patrimoniale 22

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Cash & Equivalents	$79M	$61M	$75M	$59M	$78M	$51M	$55M	$60M	$73M	$90M	$127M	$61M	$45M	$49M	$30M	$50M
Short-term Investments	·	·	·	·	·	·	·	·	·	·	·	·	·	·	·	$264M
Receivables	$1M	$3M	$2M	$7M	$2M	$8M	$3M	$10M	$1M	$14M	$12M	$500.0K	$1M	$528.0K	$1M	$1M
Prepaid Expense	$8M	$7M	$7M	$8M	$8M	$9M	$10M	$7M	$11M	$8M	$6M	$7M	$6M	$8M	$10M	$10M
Current Assets	$263M	$245M	$258M	$207M	$225M	$233M	$258M	$273M	$276M	$280M	$271M	$224M	$274M	$278M	$288M	$325M
PP&E (Net)	$4M	$4M	$5M	$5M	$6M	$5M	$6M	$6M	$7M	$7M	$7M	$7M	$8M	$8M	$7M	$7M
PP&E (Gross)	$16M	$16M	$16M	$16M	$16M	$15M	$15M	$15M	$15M	$15M	$15M	$15M	$15M	$16M	$16M	$15M
Accum. Depreciation	$11M	$11M	$11M	$10M	$10M	$10M	$9M	$9M	$9M	$8M	$8M	$8M	$8M	$9M	$8M	$8M
Other Non-current Assets	$4M	$4M	$4M	$211.0K	$178.0K	$3M	$3M	$5M	$3M	$5M	$3M	$3M	$3M	$3M	$2M	$1M
Total Assets	$359M	$329M	$359M	$265M	$297M	$320M	$350M	$376M	$381M	$398M	$376M	$333M	$375M	$396M	$431M	$461M
Accounts Payable	$1M	$773.0K	$858.0K	$1M	$2M	$683.0K	$1M	$2M	$913.0K	$2M	$1M	$1M	$2M	$1M	$1M	$2M
Current Liabilities	$48M	$27M	$33M	$36M	$44M	$41M	$45M	$43M	$54M	$55M	$43M	$30M	$48M	$39M	$45M	$45M
Capital Leases	$50M	$52M	$54M	$55M	$57M	$58M	$60M	$61M	$63M	$64M	$66M	$67M	$68M	$70M	$71M	$72M
Total Liabilities	$112M	$95M	$102M	$111M	$122M	$124M	$134M	$133M	$134M	$140M	$130M	$117M	$141M	$134M	$142M	$143M
Long-term Debt	·	·	·	·	·	·	·	·	·	·	·	$0	$10M	$12M	$11M	$11M
Total Debt	·	·	·	·	·	·	·	·	·	·	·	·	·	$11M	·	$11M
Common Stock	$12.0K	$10.0K	$9.0K	$7.0K	$7.0K	$7.0K	$7.0K	$7.0K	$7.0K	$7.0K	$6.0K	$5.0K	$5.0K	$5.0K	$5.0K	$5.0K
Retained Earnings	$-787M	$-764M	$-739M	$-718M	$-686M	$-660M	$-634M	$-599M	$-574M	$-557M	$-528M	$-494M	$-467M	$-431M	$-396M	$-359M
AOCI	$-444.0K	$-322.0K	$50.0K	$87.0K	$-30.0K	$43.0K	$53.0K	$455.0K	$-440.0K	$-380.0K	$-127.0K	$-904.0K	$-2M	$-2M	$-4M	$-5M
Stockholders' Equity	$247M	$234M	$257M	$154M	$174M	$195M	$216M	$243M	$247M	$258M	$246M	$216M	$234M	$262M	$289M	$318M
Liabilities + Equity	$359M	$329M	$359M	$265M	$297M	$320M	$350M	$376M	$381M	$398M	$376M	$333M	$375M	$396M	$431M	$461M
Shares Outstanding	122,905,756	104,036,350	96,914,418	74,174,515	71,007,083	70,989,661	70,625,899	70,562,901	68,815,642	68,778,591	60,467,188	49,259,870	49,065,098	49,052,509	48,966,216	48,951,283

Flusso di cassa 11

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
D&A	$292.0K	$404.0K	·	$460.0K	$615.0K	$456.0K	·	$442.0K	$448.0K	$448.0K	·	$447.0K	·	·	·	·
Stock-based Comp	$3M	$3M	$4M	$5M	$5M	$6M	$8M	$9M	$6M	$6M	$6M	$8M	$6M	$6M	$7M	$6M
Other Non-cash	·	$-8M	·	·	·	$-13M	·	·	·	·	·	·	·	·	·	·
Operating Cash Flow	$-2M	$-30M	$-22M	$-31M	$-12M	$-33M	$-18M	$-24M	$-5M	$-18M	$-24M	$-31M	$-19M	$-33M	$-29M	$-28M
CapEx	$37.0K	$64.0K	$11.0K	$411.0K	$185.0K	$0	$-4.0K	$-13.0K	$197.0K	$0	$157.0K	$600.0K	$362.0K	$589.0K	$1M	$3M
Investing Cash Flow	$-15M	$16M	$-81M	$4M	$39M	$29M	$14M	$162.0K	$-12M	$-53M	$32M	$58M	$15M	$54M	$9M	$20M
Stock Repurchased	$0	$200.0K	$14.0K	$24.0K	$0	$155.0K	$0	$85.0K	$0	$109.0K	$0	$16.0K	$0	$94.0K	$0	$0
Net Stock Activity	·	$-200.0K	·	·	·	$-155.0K	·	·	·	$-109.0K	·	·	·	$-94.0K	·	·
Financing Cash Flow	$34M	$462.0K	$119M	$8M	$0	$-46.0K	$112.0K	$11M	$135.0K	$35M	$58M	$-11M	$-746.0K	$-684.0K	$47.0K	$361.0K
Net Change in Cash	$17M	$-13M	$16M	$-19M	$27M	$-4M	$-4M	$-13M	$-17M	$-37M	$66M	$16M	$-5M	$20M	$-20M	$-8M
Free Cash Flow	·	$-30M	·	·	·	·	·	·	·	$-18M	·	·	·	$-34M	·	·

Redditività 7

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Operating Margin	-397.9%	-451.6%	·	-306.4%	-441.0%	-402.9%	·	-183.9%	-178.6%	-1060.2%	·	-251.2%	-1410.2%	-963.8%	·	-481.0%
Net Margin	-355.9%	-408.5%	·	-286.4%	-402.6%	-363.7%	·	-160.6%	-147.6%	-933.2%	·	-244.2%	-1348.4%	-925.2%	·	-473.2%
Pretax Margin	·	·	·	-286.4%	-402.6%	-363.7%	·	-160.6%	-147.6%	-933.2%	·	-235.1%	·	·	·	·
EBITDA Margin	-397.9%	-445.1%	·	-306.4%	-441.0%	-396.6%	·	-183.9%	-178.6%	-1060.2%	·	-251.2%	-1410.2%	-963.8%	·	-481.0%
ROA	-7.2%	-7.8%	·	-8.8%	-6.6%	-7.6%	·	·	·	-7.8%	·	·	·	-7.6%	·	-6.6%
ROE	-11.2%	-11.7%	·	-13.6%	-10.0%	-12.0%	·	·	·	-12.0%	·	·	·	-11.1%	·	-8.9%
ROIC	·	·	·	-22.3%	·	-14.9%	·	·	·	-12.5%	·	·	·	·	·	·

Liquidità e Solvibilità 4

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Current Ratio	5.4	9.0	·	5.8	5.1	5.7	·	·	·	5.1	·	·	·	7.1	·	7.2
Quick Ratio	1.7	2.4	·	1.8	1.8	1.5	·	·	·	1.9	·	·	·	1.3	·	7.0
Debt / Equity	·	·	·	·	·	·	·	·	·	·	·	·	·	0.0	·	0.0
LT Debt / Equity	·	·	·	·	·	·	·	·	·	·	·	·	·	0.0	·	0.0

Efficienza 2

Metrica	Tendenza	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Asset Turnover		0.0	0.0	·	0.0	0.0	0.0	·	·	·	0.0	·	·	·	0.0	·	0.0
Receivables Turnover		3.8	1.1	·	2.8	3.3	0.8	·	·	·	0.4	·	·	·	3.3	·	2.1

Per Azione 5

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Book Value / Share	$2.01	$2.25	·	$2.08	$2.45	$2.75	·	·	·	$3.76	·	·	·	$5.35	·	$6.50
Revenue / Share	$0.05	$0.05	·	$0.15	$0.09	$0.10	·	$0.22	$0.17	$0.04	·	$0.23	$0.05	$0.08	·	$0.14
Cash Flow / Share	·	$-0.24	·	·	·	$-0.47	·	·	·	$-0.26	·	·	·	$-0.68	·	·
Cash / Share	$0.64	$0.59	·	$0.79	$1.10	$0.72	·	·	·	$1.30	·	·	·	$1.01	·	$1.01
EPS (TTM)	$-0.91	$-1.10	·	$-1.68	$-1.59	$-1.48	·	$-1.70	$-1.90	$-2.37	·	$-2.75	$-2.85	$-2.68	·	$-2.17

Valutazione (TTM) 11

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue TTM	$35M	$35M	·	$30M	$34M	$40M	·	$34M	$29M	$20M	·	$20M	$16M	$27M	·	$48M
Net Income TTM	$-101M	$-104M	·	$-119M	$-112M	$-103M	·	$-105M	$-108M	$-126M	·	$-135M	$-140M	$-131M	·	$-107M
Market Cap	$574M	$274M	·	$165M	$102M	$114M	·	·	·	$562M	·	·	·	$154M	·	$429M
Enterprise Value	·	·	·	·	·	·	·	·	·	·	·	·	·	$115M	·	$127M
P/E	-5.1	-2.4	·	-1.3	-0.9	-1.1	·	-3.4	-2.4	-3.4	·	-0.7	-1.0	-1.2	·	-4.0
P/S	16.4	7.8	·	5.5	3.0	2.9	·	·	10.8	28.0	·	4.5	8.4	5.7	·	8.9
P/B	2.3	1.2	·	1.1	0.6	0.6	·	·	·	2.2	·	·	·	0.6	·	1.3
P / Tangible Book	2.3	1.2	·	1.1	0.6	0.6	·	·	·	2.2	·	·	·	0.6	·	1.3
P / Cash Flow	·	-9.1	·	·	·	-3.4	·	·	·	-31.0	·	·	·	-4.6	·	·
EV / Revenue	·	·	·	·	·	·	·	·	·	·	·	1.5	6.3	4.2	·	2.6
Earnings Yield	-19.5%	-41.8%	·	-75.7%	-111.2%	-92.5%	·	-29.8%	-41.1%	-29.0%	·	-147.8%	-103.6%	-85.4%	·	-24.7%

Periodo più recente a sinistra · valori nulli mostrati come ·

Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni

16

Metrica	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Ricavi	$36M	$36M	$21M	$31M	$46M
Margine Operativo %	-320.5%	-336.1%	-669.8%	-416.6%	·
Utile netto	$-105M	$-105M	$-132M	$-128M	$-84M
EPS Diluito	$-1.27	$-1.52	$-2.67	$-2.62	$-1.82

Metrica	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Debito / Patrimonio Netto	·	·	0.0	0.0	0.0
Rapporto corrente	7.8	5.7	6.3	6.5	6.4
Quick Ratio	2.3	1.3	3.2	0.7	6.1

Metrica	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Flusso di cassa libero	$-99M	$-65M	$-109M	$-111M	$-88M

Proprietari istituzionali (13F) 162 filer · $544.7M totale · Aggiornato al 30 Giugno 2026

17

Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.

Detentori 162

Valore detenuto $544.7M

Nuove posizioni 55

Posizioni chiuse 25

Attività istituzionale — Q2 2026 vs trimestre precedente

Nuove posizioni	Posizioni chiuse	Aumentato	Diminuito	Variazione netta delle azioni
55 (+18 vs trimestre precedente)	25 (+16 vs trimestre precedente)	54 (+11 vs trimestre precedente)	30 (+1 vs trimestre precedente)	+30.8M

Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.

Istituzione	Valore	Azioni	% di 13F tracciati	Tipo
MORGAN STANLEY	$41.410.468	8.867.338	7,60%	Azioni
RA CAPITAL MANAGEMENT, L.P.	$37.360.000	8.000.000	6,86%	Azioni
BlackRock, Inc.	$36.877.672	7.896.718	6,77%	Azioni
Lynx1 Capital Management LP	$34.215.647	7.326.691	6,28%	Azioni
Squadron Capital Management LLC	$33.624.000	7.200.000	6,17%	Azioni
Bain Capital Life Sciences Investors, LLC	$33.492.820	7.171.910	6,15%	Azioni
JPMORGAN CHASE & CO	$20.651.295	4.747.424	3,79%	Azioni
VANGUARD CAPITAL MANAGEMENT LLC	$20.630.804	4.417.731	3,79%	Azioni
CITADEL ADVISORS LLC	$19.555.999	4.187.580	3,59%	Azioni
GOLDMAN SACHS GROUP INC	$16.489.728	3.530.991	3,03%	Azioni
TWO SIGMA INVESTMENTS, LP	$16.203.532	3.469.707	2,97%	Azioni
Soleus Capital Management, L.P.	$15.775.171	3.377.981	2,90%	Azioni
SILVERARC CAPITAL MANAGEMENT, LLC	$14.159.720	3.032.060	2,60%	Azioni
BANK OF AMERICA CORP /DE/	$12.405.197	2.656.359	2,28%	Azioni
GEODE CAPITAL MANAGEMENT, LLC	$11.780.697	2.522.163	2,16%	Azioni
Ikarian Capital, LLC	$11.362.110	2.433.000	2,09%	Azioni
STATE STREET CORP	$9.879.950	2.115.621	1,81%	Azioni
Candriam S.C.A.	$8.383.622	1.796.937	1,54%	Azioni
VANGUARD GROUP INC	$8.365.446	4.379.815	1,54%	Azioni
D. E. Shaw & Co., Inc.	$8.130.419	1.740.989	1,49%	Azioni
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$8.089.421	1.732.210	1,49%	Azioni
WASATCH ADVISORS LP	$7.789.431	2.961.761	1,43%	Azioni
Patient Square Capital LP	$7.513.166	1.608.815	1,38%	Azioni
HighVista Strategies LLC	$6.295.800	1.348.136	1,16%	Azioni
RENAISSANCE TECHNOLOGIES LLC	$5.556.497	1.189.828	1,02%	Azioni
DIMENSIONAL FUND ADVISORS LP	$5.546.166	1.188.507	1,02%	Azioni
NORTHERN TRUST CORP	$5.419.754	1.160.547	0,99%	Azioni
CONGRESS ASSET MANAGEMENT CO	$4.686.051	1.003.437	0,86%	Azioni
FMR LLC	$4.175.231	894.054	0,77%	Azioni
UBS Group AG	$3.871.289	828.970	0,71%	Azioni
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	$3.647.550	781.060	0,67%	Azioni
BOOTHBAY FUND MANAGEMENT, LLC	$3.438.666	736.331	0,63%	Azioni
VANGUARD PORTFOLIO MANAGEMENT LLC	$3.176.039	680.094	0,58%	Azioni
VANGUARD FIDUCIARY TRUST CO	$2.844.712	609.146	0,52%	Azioni
ExodusPoint Capital Management, LP	$2.709.511	580.195	0,50%	Azioni
Velan Capital Investment Management LP	$2.661.900	570.000	0,49%	Azioni
STEMPOINT CAPITAL LP	$2.445.436	523.648	0,45%	Azioni
Rockefeller Capital Management L.P.	$2.315.465	495.817	0,43%	Azioni
Nuveen, LLC	$2.260.326	484.010	0,41%	Azioni
WELLS FARGO & COMPANY/MN	$2.114.113	452.701	0,39%	Azioni
TWO SIGMA ADVISERS, LP	$2.040.262	1.068.200	0,37%	Azioni
Man Group plc	$1.908.386	408.648	0,35%	Azioni
Squadron Capital Management LLC	$1.868.000	400.000	0,34%	Opzione Call
PLATINUM INVESTMENT MANAGEMENT LTD	$1.796.857	384.766	0,33%	Azioni
Seven Fleet Capital Management LP	$1.780.059	381.169	0,33%	Azioni
Qube Research & Technologies Ltd	$1.730.487	370.554	0,32%	Azioni
Atom Investors LP	$1.701.519	364.351	0,31%	Azioni
Susquehanna Portfolio Strategies, LLC	$1.564.819	335.079	0,29%	Azioni
ADAGE CAPITAL PARTNERS GP, L.L.C.	$1.517.750	325.000	0,28%	Azioni
JANE STREET GROUP, LLC	$1.413.843	302.750	0,26%	Azioni

Mostra tutti i 162 proprietari istituzionali →

Attivisti e proprietari del 5%+ 1 partecipazione

18

Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.

Depositante	Depositato	Partecipazione	Stato	Scopo	Deposito
Cobro Ventures Opportunity Fund, L.P., Cobro Opportunity Fund GP, LLC, Marc Cohen, Alain Cohen, Todd Kaloudis ×2 depositi	15 Giugno 2021	·	Deposito iniziale	·	SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Insider aziendali 27 insider · 13 dirigenti · 15 direttori

19

Insider	Ruolo	Ultima attività	Azioni possedute	Vendite 12m	Netto 12m
Andrew Hirsch	President & CEO	15 Febbraio 2026 F	1.074.934	0	$0
Kendra Adams	Chief Financial Officer	18 Settembre 2026 F	382.323	0	$0
Lauren White	Chief Financial Officer	30 Agosto 2023 M	32.686	0	$0
William Mckee	Chief Financial Officer	06 Ottobre 2020 P	5.263	0	$0
Leonard Reyno	Chief Medical Officer	10 Luglio 2026 F	372.406	1	$-22.200
Paige Mahaney	Chief Scientific Officer	14 Febbraio 2026 F	336.910	0	$0
Mark Mossler	Chief Accounting Officer	14 Febbraio 2026 F	71.916	0	$0
Scott N Boyle	Chief Business Officer	14 Febbraio 2026 F	298.801	0	$0
Kelly Schick	Chief People Officer	14 Febbraio 2026 F	299.881	0	$0
Jolie Siegel	Chief Legal Officer	14 Febbraio 2025 A	107.939	0	$0
Stewart Fisher	Chief Scientific Officer	16 Settembre 2024 M	130.710	0	$0
Adam Crystal	Chief Medical Officer	30 Gennaio 2023 M	20.097	0	$0
Laura Jean Wahlberg	VP of Finance Corp Controller	11 Febbraio 2021 A	·	0	$0
Kenneth Carl Anderson	Direttore	01 Ottobre 2026 A	75.612	0	$0
Donna Roy Grogan	Direttore	01 Ottobre 2026 A	79.471	0	$0
Stephen Fawell	Direttore	24 Giugno 2026 A	·	0	$0
Laura Bessen	Direttore	24 Giugno 2026 A	·	0	$0
Utpal Koppikar	Direttore	24 Giugno 2026 A	5.667	0	$0
Ronald Harold Wilfred Cooper	Direttore	24 Giugno 2026 A	·	0	$0
Owen Hughes	Direttore	24 Giugno 2026 A	·	0	$0
Steven L. Hoerter	Direttore	24 Giugno 2026 A	·	0	$0
Malcolm Salter	Direttore	20 Giugno 2024 A	11.380	0	$0
Bruce Downey	Direttore	20 Giugno 2024 A	489.542	0	$0
Glenn Dubin	Direttore	01 Aprile 2024 A	22.075	0	$0
Marc A Cohen	Direttore	22 Giugno 2022 A	1.118	0	$0
Alain J Cohen	Direttore	04 Aprile 2022 A	928	0	$0
Elena Prokupets	Direttore	27 Settembre 2021 S	503.126	0	$0

Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato

Proprietà ETF Posseduti da 20 ETF

20

Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.

Fondo	Peso	Unità	Aggiornato al	Fonte
QQQS · Invesco Exchange-Traded Fund Trust …	0,46%	32.308 SH	01 Ottobre 2026	Giornaliero
IWC · iShares Trust	0,08%	342.369 SH	11 Settembre 2026	Giornaliero
VTWV · VANGUARD SCOTTSDALE FUNDS	0,03%	88.122 SH	19 Agosto 2026	Giornaliero
IBB · iShares Trust	0,03%	845.464 SH	11 Settembre 2026	Giornaliero
PRFZ · Invesco Exchange-Traded Fund Trust	0,03%	222.078 SH	01 Ottobre 2026	Giornaliero
IBBQ · Invesco Exchange-Traded Fund Trust …	0,03%	8.690 SH	01 Ottobre 2026	Giornaliero
IWM · iShares Trust	0,01%	2.614.567 SH	11 Settembre 2026	Giornaliero
RSSL · Global X Funds	0,01%	48.213 NS	31 Luglio 2026	N-PORT
VTWO · VANGUARD SCOTTSDALE FUNDS	0,01%	583.446 SH	19 Agosto 2026	Giornaliero
DFAS · Dimensional ETF Trust	0,01%	235.215 NS	31 Luglio 2026	N-PORT
DXUV · Dimensional ETF Trust	0,00%	3.906 NS	31 Luglio 2026	N-PORT
DCOR · Dimensional ETF Trust	0,00%	14.611 NS	31 Luglio 2026	N-PORT
DFSU · Dimensional ETF Trust	0,00%	8.504 NS	31 Luglio 2026	N-PORT
DFAC · Dimensional ETF Trust	0,00%	115.180 NS	31 Luglio 2026	N-PORT
DFAU · Dimensional ETF Trust	0,00%	19.202 NS	31 Luglio 2026	N-PORT
DFUS · Dimensional ETF Trust	0,00%	21.036 NS	31 Luglio 2026	N-PORT
VXF · VANGUARD INDEX FUNDS	0,00%	1.046.993 SH	19 Agosto 2026	Giornaliero
VTI · VANGUARD INDEX FUNDS	0,00%	3.264.924 SH	19 Agosto 2026	Giornaliero
VTHR · VANGUARD SCOTTSDALE FUNDS	0,00%	8.526 SH	19 Agosto 2026	Giornaliero
IWN · iShares Trust	·	926.223 SH	11 Settembre 2026	Giornaliero

CCCC Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo

21

rating · 13 analisti COMPRA

Target mediano $11.00 +272,9%

4 30,8% Acquisto forte

8 61,5% Compra

1 7,7% Mantieni

0 0,0% Vendi

0 0,0% Vendita forte

Target Price a 12 Mesi

6 analisti · 2026-09-30

Target medio $13.33 +352,0%

← Sotto tutti i target Prezzo attuale $2.95

Basso$7.00 Media$13.33 Alto$30.00

Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore

22

Base FY, prezzi alla chiusura dell'ultimo anno fiscale di ciascuna società.

Ticker	Capitalizzazione di Mercato	P/E	Rev YoY	Margine Netto	ROE	Margine lordo
CCCC	$185M	-1.5	1.0%	-292.1%	-48.8%	·
MYGN	$575M	-1.6	-1.6%	-44.4%	-96.8%	69.9%
RZLT	$501M	-6.9	·	·	-67.8%	·
KYTX	$568M	-2.6	·	·	-77.4%	·
SPRY	$1.16B	-6.7	-5.5%	-203.3%	-111.8%	·
EIKN	·	·	·	·	·	·
EDIT	$201M	-1.1	25.4%	-395.0%	-688.8%	·
GALT	$271M	-8.7	·	·	25.0%	·
IRD	$140M	-2.5	29.1%	-349.3%	-302.2%	·
AGEN	$111M	·	10.4%	-2.7%	1.0%	·

Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi

26

Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.

La tua selezione è salvata e ti segue su tutti i ticker.

CCCC C4 Therapeutics, Inc. - Common Stock